Scindo, a UK-based startup developing a data-rich AI platform to discover and design next-generation enzymes, has raised £4 million in funding co-led by Kadmos Capital and Clay Capital, with participation from PINC, the venture arm of international food and beverage company Paulig, and existing investors Synbioven, AgFunder, SOSV, Farvatn Venture and Savantus Ventures. The investment will accelerate Scindo's mission to enable bio-based ingredients and sustainable chemistry across multiple high-value sectors.
Scindo's full-stack platform designs enzymes, which are naturally occurring catalytic proteins found in all living organisms, to transform renewable feedstocks into high-value, bio-based ingredients. By combining advanced AI models with proprietary, experimentally validated reaction data, and rich meta data, the platform accelerates enzyme discovery and optimisation, enabling complex reactions to be done more efficiently and sustainably. This innovation supports consistent, scalable production of natural ingredients across food, flavourings, cosmetics and other specialty chemical applications.
The company's technology is already attracting strong industry interest, with established partnerships with leading specialty chemical manufacturers and pilot scaling initiatives underway to bring the first products to market. This momentum underscores the rising demand for bio-based solutions that can deliver both performance and sustainability at scale.
Founded in 2020, Scindo is entering its next phase of growth. With the new funding, the company will expand its enzyme discovery engine, scale wet-lab capabilities and strengthen its team. Recent hires include research scientists from top pharma companies and the University of Oxford, bolstering expertise in machine learning, enzyme engineering, process scaling and commercialisation.
